Role of PD-L1 in Gut Mucosa Tolerance and Chronic Inflammation

被引:28
作者
Chulkina, Marina [1 ]
Beswick, Ellen J. [2 ]
Pinchuk, Irina, V [1 ]
机构
[1] Penn State Hlth Milton S Hershey Med Ctr, Dept Med, Hershey, PA 17033 USA
[2] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA
关键词
PD-L1; gastrointestinal inflammation; homeostasis; inflammatory bowel disease; CHECKPOINT INHIBITOR THERAPY; CD4(+) T-CELLS; DEATH LIGAND 1; IFN-GAMMA; INTESTINAL INFLAMMATION; HELICOBACTER-PYLORI; CROHNS-DISEASE; LAMINA PROPRIA; CELIAC-DISEASE; B7; FAMILY;
D O I
10.3390/ijms21239165
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The gastrointestinal (GI) mucosa is among the most complex systems in the body. It has a diverse commensal microbiome challenged continuously by food and microbial components while delivering essential nutrients and defending against pathogens. For these reasons, regulatory cells and receptors are likely to play a central role in maintaining the gut mucosal homeostasis. Recent lessons from cancer immunotherapy point out the critical role of the B7 negative co-stimulator PD-L1 in mucosal homeostasis. In this review, we summarize the current knowledge supporting the critical role of PD-L1 in gastrointestinal mucosal tolerance and how abnormalities in its expression and signaling contribute to gut inflammation and cancers. Abnormal expression of PD-L1 and/or the PD-1/PD-L1 signaling pathways have been observed in the pathology of the GI tract. We also discuss the current gap in our knowledge with regards to PD-L1 signaling in the GI tract under homeostasis and pathology. Finally, we summarize the current understanding of how this pathway is currently targeted to develop novel therapeutic approaches.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 115 条
  • [1] Immune Checkpoint Inhibitor Therapy in Patients With Preexisting Inflammatory Bowel Disease
    Abu-Sbeih, Hamzah
    Faleck, David M.
    Ricciuti, Biagio
    Mendelsohn, Robin B.
    Naqash, Abdul R.
    Cohen, Justine V.
    Sellers, Maclean C.
    Balaji, Aanika
    Ben-Betzalel, Guy
    Hajir, Ibraheim
    Zhang, Jiajia
    Awad, Mark M.
    Leonardi, Giulia C.
    Johnson, Douglas B.
    Pinato, David J.
    Owen, Dwight H.
    Weiss, Sarah A.
    Lamberti, Giuseppe
    Lythgoe, Mark P.
    Manuzzi, Lisa
    Arnold, Christina
    Qiao, Wei
    Naidoo, Jarushka
    Markel, Gal
    Powell, Nick
    Yeung, Sai-Ching J.
    Sharon, Elad
    Dougan, Michael
    Wang, Yinghong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06) : 576 - +
  • [2] Matrix metalloproteinases cleave membrane-bound PD-L1 on CD90+ (myo-)fibroblasts in Crohn's disease and regulate Th1/Th17 cell responses
    Aguirre, Jose E.
    Beswick, Ellen J.
    Grim, Carl
    Uribe, Gabriela
    Tafoya, Marissa
    Palma, Gabriela Chacon
    Samedi, Von
    McKee, Rohini
    Villeger, Romain
    Fofanov, Yuriy
    Cong, Yingzi
    Yochum, Gregory
    Koltun, Walter
    Powell, Don
    Pinchuk, Irina, V
    [J]. INTERNATIONAL IMMUNOLOGY, 2020, 32 (01) : 57 - 68
  • [3] Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies
    Ahluwalia, Bani
    Moraes, Luiza
    Magnusson, Maria K.
    Ohman, Lena
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (04) : 379 - 389
  • [4] Effect of Helicobacter pylori on gastric epithelial cells
    Alzahrani, Shatha
    Lina, Taslima T.
    Gonzalez, Jazmin
    Pinchuk, Irina V.
    Beswick, Ellen J.
    Reyes, Victor E.
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (36) : 12767 - 12780
  • [5] TGFβ-dependent expression of PD-1 and PD-L1 controls CD8+ T cell anergy in transplant tolerance
    Baas, Marije
    Besancon, Alix
    Goncalves, Tania
    Valette, Fabrice
    Yagita, Hideo
    Sawitzki, Birgit
    Volk, Hans-Dieter
    Waeckel-Enee, Emmanuelle
    Rocha, Benedita
    Chatenoud, Lucienne
    You, Sylvaine
    [J]. ELIFE, 2016, 5
  • [6] Checkpoint Inhibitor-Induced Colitis
    Bellaguarda, Emanuelle
    Hanauer, Stephen
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 (02) : 202 - 210
  • [7] Expression of the programmed death ligand 1, b7-h1,on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells
    Beswick, Ellen J.
    Pinchuk, Irina V.
    Das, Sournita
    Powell, Don W.
    Reyes, Victor E.
    [J]. INFECTION AND IMMUNITY, 2007, 75 (09) : 4334 - 4341
  • [8] Expression of Programmed Death-Ligand 1 by Human Colonic CD90+ Stromal Cells Differs Betweem Ulcerative Colitis and Crohn's Disease and Determines Their Capacity to Suppress Th1 Cells
    Beswick, Ellen J.
    Grim, Carl
    Singh, Abinav
    Aguirre, Jose E.
    Tafoya, Marissa
    Qiu, Suimin
    Rogler, Gerhard
    McKee, Rohini
    Samedi, Von
    Ma, Thomas Y.
    Reyes, Victor E.
    Powell, Don W.
    Pinchuk, Irina V.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] TLR4 Activation Enhances the PD-L1-Mediated Tolerogenic Capacity of Colonic CD90+ Stromal Cells
    Beswick, Ellen J.
    Johnson, Jameel R.
    Saada, Jamal I.
    Humen, Martin
    House, Jenifer
    Dann, Sara
    Qiu, Suimin
    Brasier, Allan R.
    Powell, Don W.
    Reyes, Victor E.
    Pinchuk, Irina V.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 193 (05) : 2218 - 2229
  • [10] Blockade of programmed death-1 Ligands on dendritic cells enhances T cell activation and cytokine production
    Brown, JA
    Dorfman, DM
    Ma, FR
    Sullivan, EL
    Munoz, O
    Wood, CR
    Greenfield, EA
    Freeman, GJ
    [J]. JOURNAL OF IMMUNOLOGY, 2003, 170 (03) : 1257 - 1266